| abstract |
Provided is a pharmaceutical composition for combination therapy. (A) The construction of a functionally effective complex for therapeutically effective amounts of inhibiting the activity of RAD51, preventing the formation of RAD51 foci, or for homologous recombination of DNA. Use of at least one agent that interferes, and (b) a therapeutic agent capable of damaging cellular DNA, for the manufacture of a medicament for use in treating cancer, wherein the agent comprises 3-((dimethylamino Use) which is)) methyl) -N- (2- (4- (hydroxycarbamoyl) phenoxy) ethyl) benzofuran-2-carboxamide. [Selection figure] None |